Richard Vosser Stock Analyst Profile - JP Morgan Research Coverage - Stocknear

Richard Vosser

Stock Analyst at JP Morgan

(4.83)
# 802
Out of 5,477 analysts
14
Total ratings
Success rate
Average return
6 Stocks
Name Action PT Current % Upside Ratings Updated
MOLN Molecular Partners
Maintains: Neutral
5 4
3.78 5.82% 2 Sep 3, 2025
SNY Sanofi
Upgrades: Overweight
n/a
n/a n/a 2 Aug 8, 2025
MOR MorphoSys
Maintains: Overweight
10 9
18.96 -55.17% 3 Dec 5, 2023
NVO Novo Nordisk
Upgrades: Overweight
n/a
n/a n/a 5 Jun 7, 2022
UCBJY UCB
Upgrades: Overweight
n/a
n/a n/a 1 Sep 2, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Overweight
n/a
n/a n/a 1 Feb 23, 2021